medvisМедицинская визуализацияMedical Visualization1607-07632408-9516RDS-Media Ltd.10.24835/10.24835/1607-0763-1088medvis-1088Research ArticleОТ ПРИГЛАШЕННОГО РЕДАКТОРАFROM THE INVITED EDITORКонтраст-индуцированное острое почечное повреждение: современное состояние вопросаContrast-induced acute renal injury: the modern state of issuehttps://orcid.org/0000-0002-5649-2193СиницынВ. Е.SinitsinV. E.

Синицын Валентин Евгеньевич – доктор мед. наук, профессор, заведующий отделом лучевой диагностики; заведующий кафедрой лучевой диагностики и лучевой терапии факультета фундаментальной медицины

Scopus ID 7102735724

119192 Москва, Ломоносовский проспект, 27, к. 10

Valentin E. Sinitsin – Doct. of Sci. (Med.), Professor, Head of Radiology department, Chief of Radiology and Radiotherapy Chair, Faculty of Fundamental Medicine

Scopus ID 7102735724

27-10, Lomonosovsky prospekt, 119192, Moscow

vsini@mail.ruhttps://orcid.org/0000-0002-0894-1994ФилатоваД. А.FilatovaD. A.

Филатова Дарья Андреевна – клинический ординатор кафедры лучевой диагностики и лучевой терапии

143433 Московская обл., Красногорский р-н, п. Нахабино, ул. Школьная, 1а

119192 Москва, Ломоносовский проспект, 27, к. 10

Darya A. Filatova – Resident of Radiology and Radiotherapy Department

1a, Shkolnaya str., Nakhabino 143433, Krasnogorsk distr., Moscow reg. 

27-10, Lomonosovsky prospekt, 119192, Moscow

dariafilatova.msu@mail.ruhttps://orcid.org/0000-0002-1266-4926МершинаЕ. А.MershinaE. A.

Мершина Елена Александровна – канд. мед. наук, доцент кафедры лучевой диагностики и лучевой терапии, заведующая отделением рентгенодиагностики с кабинетами МРТ и КТ

119192 Москва, Ломоносовский проспект, 27, к. 10

Elena A. Mershina – Cand. of Sci. (Med.), assistant professor of Radiology and Radiotherapy Chair, Faculty of Fundamental Medicine; Head of Radiology department

27-10, Lomonosovsky prospekt, 119192, Moscow

elena_mershina@mail.ruМедицинский научно-образовательный центр ФГБОУ ВО “Московский государственный университет имени М.В. Ломоносова”РоссияMedical Research and Education Center of Lomonosov Moscow State UniversityRussian Federation2022050320222612739Copyright © Синицын В.Е., Филатова Д.А., Мершина Е.А., 20222022Синицын В.Е., Филатова Д.А., Мершина Е.А.Sinitsin V.E., Filatova D.A., Mershina E.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://medvis.rdsmedia.ru/jour/article/view/1088

Понятие “контраст-индуцированное острое почечное повреждение” (КИ-ОПП) представляет собой подъем уровня креатинина плазмы крови, зафиксированный в течение 48 ч после введения контрастного препарата. Данное состояние является третьей по частоте причиной хронической почечной недостаточности, возникающей в стационаре. Несмотря на довольно частую встречаемость данного явления, до конца не ясно, действительно ли все подобные случаи можно объяснить исключительно широким распространением процедур с введением контрастного препарата, ведь снижение функции почек зачастую встречается и у стационарных пациентов, которым не вводили контрастный препарат. Так как схемы лечения КИ-ОПП не существует, многие группы ученых предпринимали попытки разработать схему профилактики. Однако такие мероприятия сопряжены с рядом сложностей: возможные последствия для пациентов, логистические трудности в лечебном учреждении, экономические затраты. Эффективность данных мероприятий также однозначно не доказана. В частности, в ходе крупного исследования AMACING было показано, что гидратация не снижает вероятность развития КИ-ОПП, но существенно увеличивает расходы на лечение пациента и может вызвать специфические осложнения. Кроме того, много литературных данных свидетельствует в пользу того, что методика гидратации эффективна для предотвращения снижения функции почек лишь у пациентов, которые подверглись внутриартериальному введению контрастного препарата. Таким образом, необходимость медикаментозной профилактики КИ-ОПП в настоящее время подвергается сомнению; исследования в этой области активно продолжаются.

The concept of “contrast-induced acute renal injury” (CI-AKI) is an increase in the level of plasma creatinine, recorded within 48 hours after contrast drug administration. This condition is the third most common cause of chronic renal failure occurring in a hospital. Despite the rather frequent occurrence of this phenomenon, it is not completely clear whether all such cases can really be explained by the exceptionally wide spread of procedures with contrast agent administration, because a decrease in kidney function is often found in inpatient patients. Since there is no treatment for CI-AKI, many groups of scientists have attempted to develop a prevention regimen. However, such measures are fraught with a number of difficulties: possible consequences for patients, logistical difficulties in a medical institution, costs of funds. The effectiveness of these measures has also not been unequivocally proven. In particular, in the course of a large AMACING study, it was shown that hydration does not reduce the likelihood of developing CI-AKI, but significantly increases the patient's treatment costs and can cause specific complications. In addition, there is a lot of literature evidence in favor of the fact that the hydration technique is effective for preventing a decrease in kidney function only in patients who have undergone intra-arterial administration of a contrast agent. Thus, the need for drug prevention of CI-AKI is currently being questioned, research in this area is actively continuing.

йодсодержащий контрастный препараткомпьютерная томографияострое почечное повреждениепрофилактикапочкиiodine-containing contrast agentcomputed tomographyacute renal injurypreventionkidneysReferencesKhwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin. Pract. 2012; 120 (4): 179–184. http://doi.org/10.1159/000339789Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin. Pract. 2012; 120 (4): 179–184. http://doi.org/10.1159/000339789Thomsen H.S., Morcos S.K. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Br. J. Radiol. 2003; 76 (908): 513–518. http://doi.org/10.1259/bjr/26964464Thomsen H.S., Morcos S.K. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Br. J. Radiol. 2003; 76 (908): 513–518. http://doi.org/10.1259/bjr/26964464Ribichini F., Graziani M., Gambaro G. et al. Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. Am. J. Med. 2010; 123 (8): 755–763. http://doi.org/10.1016/j.amjmed. 2010.02.026Ribichini F., Graziani M., Gambaro G. et al. Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. Am. J. Med. 2010; 123 (8): 755–763. http://doi.org/10.1016/j.amjmed. 2010.02.026Hou S.H., Bushinsky D.A., Wish J.B. et al. Hospitalacquired renal insufficiency: a prospective study. Am. J. Med. 1983; 74 (2): 243–248. http://doi.org/10.1016/0002-9343(83)90618-6Hou S.H., Bushinsky D.A., Wish J.B. et al. Hospitalacquired renal insufficiency: a prospective study. Am. J. Med. 1983; 74 (2): 243–248. http://doi.org/10.1016/0002-9343(83)90618-6Nash K., Hafeez A., Hou S. Hospital-acquired renal insufficiency. Am. J. Kidney Dis. Off. J. Natl. Kidney Found. 2002; 39 (5): 930–936. http://doi.org/10.1053/ajkd.2002.32766Nash K., Hafeez A., Hou S. Hospital-acquired renal insufficiency. Am. J. Kidney Dis. Off. J. Natl. Kidney Found. 2002; 39 (5): 930–936. http://doi.org/10.1053/ajkd.2002.32766Cramer B.C., Parfrey P.S., Hutchinson T.A. et al. Renal function following infusion of radiologic contrast material. A prospective controlled study. Arch. Intern. Med. 1985; 145 (1): 87–89.Cramer B.C., Parfrey P.S., Hutchinson T.A. et al. Renal function following infusion of radiologic contrast material. A prospective controlled study. Arch. Intern. Med. 1985; 145 (1): 87–89.Heller C.A., Knapp J., Halliday J. et al. Failure to demonstrate contrast nephrotoxicity. Med. J. Aust. 1991; 155 (5): 329–332. http://doi.org/10.5694/j.1326-5377.1991.tb142293.x.Heller C.A., Knapp J., Halliday J. et al. Failure to demonstrate contrast nephrotoxicity. Med. J. Aust. 1991; 155 (5): 329–332. http://doi.org/10.5694/j.1326-5377.1991.tb142293.x.Bruce R.J., Djamali A., Shinki K. et al. Background fluctuation of kidney function versus contrast-induced nephrotoxicity. Am. J. Roentgenol. 2009; 192 (3): 711–718. http://doi.org/10.2214/AJR.08.1413Bruce R.J., Djamali A., Shinki K. et al. Background fluctuation of kidney function versus contrast-induced nephrotoxicity. Am. J. Roentgenol. 2009; 192 (3): 711–718. http://doi.org/10.2214/AJR.08.1413Cochran S.T., Wong W.S., Roe D.J. Predicting angiography-induced acute renal function impairment: clinical risk model. Am. J. Roentgenol. 1983; 141 (5): 1027–1033. http://doi.org/10.2214/ajr.141.5.1027Cochran S.T., Wong W.S., Roe D.J. Predicting angiography-induced acute renal function impairment: clinical risk model. Am. J. Roentgenol. 1983; 141 (5): 1027–1033. http://doi.org/10.2214/ajr.141.5.1027Itoh Y., Yano T., Sendo T., Oishi R. Clinical and Experimental Evidence for Prevention of Acute Renal Failure Induced by Radiographic Contrast Media. J. Pharmacol. Sci. 2005; 97 (4): 473–488. http://doi.org/10.1254/jphs.crj05002xItoh Y., Yano T., Sendo T., Oishi R. Clinical and Experimental Evidence for Prevention of Acute Renal Failure Induced by Radiographic Contrast Media. J. Pharmacol. Sci. 2005; 97 (4): 473–488. http://doi.org/10.1254/jphs.crj05002xMorcos S.K., Thomsen H.S., Webb J.A. Contrast-mediainduced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur. Radiol. 1999; 9 (8): 1602–1613. http://doi.org/10.1007/s003300050894Morcos S.K., Thomsen H.S., Webb J.A. Contrast-mediainduced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur. Radiol. 1999; 9 (8): 1602–1613. http://doi.org/10.1007/s003300050894Berg K.J. Nephrotoxicity related to contrast media. Scand. J. Urol. Nephrol. 2000; 34 (5): 317–322. http://doi.org/10.1080/003655900750048341Berg K.J. Nephrotoxicity related to contrast media. Scand. J. Urol. Nephrol. 2000; 34 (5): 317–322. http://doi.org/10.1080/003655900750048341Gleeson T.G., Bulugahapitiya S. Contrast-induced nephropathy. Am. J. Roentgenol. 2004; 183 (6): 1673–1689. http://doi.org/10.2214/ajr.183.6.01831673Gleeson T.G., Bulugahapitiya S. Contrast-induced nephropathy. Am. J. Roentgenol. 2004; 183 (6): 1673–1689. http://doi.org/10.2214/ajr.183.6.01831673Solomon R.J., Natarajan M.K., Doucet S. et al.; Investigators of the CARE Study. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation. 2007; 115 (25): 3189–3196. http://doi.org/10.1161/CIRCULATIONAHA.106.671644Solomon R.J., Natarajan M.K., Doucet S. et al.; Investigators of the CARE Study. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation. 2007; 115 (25): 3189–3196. http://doi.org/10.1161/CIRCULATIONAHA.106.671644Newhouse J.H., Kho D., Rao Q.A., Starren J. Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. Am. J. Roentgenol. 2008; 191 (2): 376–382. http://doi.org/10.2214/AJR.07.3280Newhouse J.H., Kho D., Rao Q.A., Starren J. Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. Am. J. Roentgenol. 2008; 191 (2): 376–382. http://doi.org/10.2214/AJR.07.3280Baumgarten D.A., Ellis J.H. Contrast-induced nephropathy: contrast material not required? Am. J. Roentgenol. 2008; 191 (2): 383–386. http://doi.org/10.2214/AJR.08.1310Baumgarten D.A., Ellis J.H. Contrast-induced nephropathy: contrast material not required? Am. J. Roentgenol. 2008; 191 (2): 383–386. http://doi.org/10.2214/AJR.08.1310McDonald J.S., McDonald R.J., Comin J. et al. Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and metaanalysis. Radiology. 2013; 267 (1): 119–128. http://doi.org/10.1148/radiol.12121460McDonald J.S., McDonald R.J., Comin J. et al. Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and metaanalysis. Radiology. 2013; 267 (1): 119–128. http://doi.org/10.1148/radiol.12121460Rudnick M.R., Goldfarb S., Wexler L. et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int. 1995; 47 (1): 254–261. http://doi.org/10.1038/ki.1995.32Rudnick M.R., Goldfarb S., Wexler L. et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int. 1995; 47 (1): 254–261. http://doi.org/10.1038/ki.1995.32Taliercio C.P., Vlietstra R.E., Ilstrup D.M. et al. A randomized comparison of the nephrotoxicity of iopamidol and diatrizoate in high risk patients undergoing cardiac angiography. J. Am. Coll. Cardiol. 1991; 17 (2): 384–390. http://doi.org/10.1016/s0735-1097(10)80103-2Taliercio C.P., Vlietstra R.E., Ilstrup D.M. et al. A randomized comparison of the nephrotoxicity of iopamidol and diatrizoate in high risk patients undergoing cardiac angiography. J. Am. Coll. Cardiol. 1991; 17 (2): 384–390. http://doi.org/10.1016/s0735-1097(10)80103-2Aspelin P., Aubry P., Fransson S.G. et al.; Nephrotoxicity in High-Risk Patients Study of Iso-Osmolar and LowOsmolar Non-Ionic Contrast Media Study Investigators. Nephrotoxic effects in high-risk patients undergoing angiography. N. Engl. J. Med. 2003; 348 (6): 491–499. http://doi.org/10.1056/NEJMoa021833Aspelin P., Aubry P., Fransson S.G. et al.; Nephrotoxicity in High-Risk Patients Study of Iso-Osmolar and LowOsmolar Non-Ionic Contrast Media Study Investigators. Nephrotoxic effects in high-risk patients undergoing angiography. N. Engl. J. Med. 2003; 348 (6): 491–499. http://doi.org/10.1056/NEJMoa021833Aspelin P., Aubry P., Fransson S.G. et al. Cost-effectiveness of iod ixanol in patients at high risk of contrast-induced nephropathy. Am. Heart J. 2005; 149 (2): 298–303. http://doi.org/10.1016/j.ahj.2004.07.020Aspelin P., Aubry P., Fransson S.G. et al. Cost-effectiveness of iod ixanol in patients at high risk of contrast-induced nephropathy. Am. Heart J. 2005; 149 (2): 298–303. http://doi.org/10.1016/j.ahj.2004.07.020Mueller C., Buerkle G., Buettner H.J. et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch. Intern. Med. 2002; 162 (3): 329–336. http://doi.org/10.1001/archinte.162.3.329Mueller C., Buerkle G., Buettner H.J. et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch. Intern. Med. 2002; 162 (3): 329–336. http://doi.org/10.1001/archinte.162.3.329Trivedi H.S., Moore H., Nasr S. et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron. Clin. Pract. 2003; 93 (1): 29–34. http://doi.org/10.1159/000066641Trivedi H.S., Moore H., Nasr S. et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron. Clin. Pract. 2003; 93 (1): 29–34. http://doi.org/10.1159/000066641Bellomo R., Kellum J.A., Ronco C. Acute kidney injury. Lancet Lond. Engl. 2012; 380 (9843): 756–766. http://doi.org/10.1016/S0140-6736(11)61454-2Bellomo R., Kellum J.A., Ronco C. Acute kidney injury. Lancet Lond. Engl. 2012; 380 (9843): 756–766. http://doi.org/10.1016/S0140-6736(11)61454-2Christiansen C. X-ray contrast media – an overview. Toxicology. 2005; 209 (2): 185–187. http://doi.org/10.1016/j.tox.2004.12.020Christiansen C. X-ray contrast media – an overview. Toxicology. 2005; 209 (2): 185–187. http://doi.org/10.1016/j.tox.2004.12.020Eisenberg R.L., Bank W.O., Hedgock M.W. Renal failure after major angiography can be avoided with hydration. Am. J. Roentgenol. 1981; 136 (5): 859–861. http://doi.org/10.2214/ajr.136.5.859Eisenberg R.L., Bank W.O., Hedgock M.W. Renal failure after major angiography can be avoided with hydration. Am. J. Roentgenol. 1981; 136 (5): 859–861. http://doi.org/10.2214/ajr.136.5.859Solomon R. Radiocontrast-induced nephropathy. Semin. Nephrol. 1998; 18 (5). Accessed March 16, 2021. https://pubmed.ncbi.nlm.nih.gov/9754608/Solomon R. Radiocontrast-induced nephropathy. Semin. Nephrol. 1998; 18 (5). Accessed March 16, 2021. https://pubmed.ncbi.nlm.nih.gov/9754608/Jurado-Román A., Hernández-Hernández F., GarcíaTejada J. et al. Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention. Am. J. Cardiol. 2015; 115 (9): 1174–1178. http://doi.org/10.1016/j.amjcard.2015.02.004Jurado-Román A., Hernández-Hernández F., GarcíaTejada J. et al. Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention. Am. J. Cardiol. 2015; 115 (9): 1174–1178. http://doi.org/10.1016/j.amjcard.2015.02.004Luo Y., Wang X., Ye Z. et al. Remedial hydration reduces the incidence of contrast-induced nephropathy and short-term adverse events in patients with ST-segment elevation myocardial infarction: a single-center, randomized trial. Intern. Med. Tokyo Jpn. 2014; 53 (20): 2265–2272. http://doi.org/10.2169/internalmedicine.53.1853Luo Y., Wang X., Ye Z. et al. Remedial hydration reduces the incidence of contrast-induced nephropathy and short-term adverse events in patients with ST-segment elevation myocardial infarction: a single-center, randomized trial. Intern. Med. Tokyo Jpn. 2014; 53 (20): 2265–2272. http://doi.org/10.2169/internalmedicine.53.1853Ad-hoc working group of ERBP, Fliser D., Laville M., Covic A. et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc – Eur. Ren. Assoc. 2012; 27 (12): 4263–4272. http://doi.org/10.1093/ndt/gfs375Ad-hoc working group of ERBP, Fliser D., Laville M., Covic A. et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc – Eur. Ren. Assoc. 2012; 27 (12): 4263–4272. http://doi.org/10.1093/ndt/gfs375Stacul F., van der Molen A.J., Reimer P. et al. ; Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur. Radiol. 2011; 21 (12): 2527–2541. http://doi.org/10.1007/s00330-011-2225-0Stacul F., van der Molen A.J., Reimer P. et al. ; Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur. Radiol. 2011; 21 (12): 2527–2541. http://doi.org/10.1007/s00330-011-2225-0Nijssen E.C., Rennenberg R.J., Nelemans P.J. et al. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, openlabel, non-inferiority trial. Lancet Lond. Engl. 2017; 389 (10076): 1312–1322. http://doi.org/10.1016/S0140-6736(17)30057-0Nijssen E.C., Rennenberg R.J., Nelemans P.J. et al. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, openlabel, non-inferiority trial. Lancet Lond. Engl. 2017; 389 (10076): 1312–1322. http://doi.org/10.1016/S0140-6736(17)30057-0Thomsen H.S. European Society of Urogenital Radiology (ESUR) guidelines on the safe use of iodinated contrast media. Eur. J. Radiol. 2006; 60 (3): 307–313. http://doi.org/10.1016/j.ejrad.2006.06.020Thomsen H.S. European Society of Urogenital Radiology (ESUR) guidelines on the safe use of iodinated contrast media. Eur. J. Radiol. 2006; 60 (3): 307–313. http://doi.org/10.1016/j.ejrad.2006.06.020Merten G.J., Burgess W.P., Gray L.V. et al. Prevention of contrast-induced nephro pathy with sodium bicarbonate: a randomized controlled trial. JAMA. 2004; 291 (19): 2328–2334. http://doi.org/10.1001/jama.291.19.2328Merten G.J., Burgess W.P., Gray L.V. et al. Prevention of contrast-induced nephro pathy with sodium bicarbonate: a randomized controlled trial. JAMA. 2004; 291 (19): 2328–2334. http://doi.org/10.1001/jama.291.19.2328Brar S.S., Shen A.Y., Jorgensen M.B. et al. Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial. JAMA. 2008; 300 (9): 1038–1046. http://doi.org/10.1001/jama.300.9.1038Brar S.S., Shen A.Y., Jorgensen M.B. et al. Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial. JAMA. 2008; 300 (9): 1038–1046. http://doi.org/10.1001/jama.300.9.1038Brar S.S., Hiremath S., Dangas G. et al. Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis. Clin. J. Am. Soc. Nephrol. CJASN. 2009; 4 (10): 1584–1592. http://doi.org/10.2215/CJN.03120509Brar S.S., Hiremath S., Dangas G. et al. Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis. Clin. J. Am. Soc. Nephrol. CJASN. 2009; 4 (10): 1584–1592. http://doi.org/10.2215/CJN.03120509Kooiman J., Sijpkens Y.W., van Buren M. et al. Randomised trial of no hydration vs. sodium bicarbonate hydration in patients with chronic kidney disease undergoing acute computed tomography-pulmonary angiography. J. Thromb. Haemost. JTH. 2014; 12 (10): 1658–1666. http://doi.org/10.1111/jth.12701Kooiman J., Sijpkens Y.W., van Buren M. et al. Randomised trial of no hydration vs. sodium bicarbonate hydration in patients with chronic kidney disease undergoing acute computed tomography-pulmonary angiography. J. Thromb. Haemost. JTH. 2014; 12 (10): 1658–1666. http://doi.org/10.1111/jth.12701Briguori C., Airoldi F., D'Andrea D. et al. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation. 2007; 115 (10): 1211–1217. http://doi.org/10.1161/CIRCULATIONAHA.106.687152Briguori C., Airoldi F., D'Andrea D. et al. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation. 2007; 115 (10): 1211–1217. http://doi.org/10.1161/CIRCULATIONAHA.106.687152Chong E., Poh K.K., Lu Q. et al. Comparison of combination therapy of high-dose oral N-acetylcysteine and intravenous sodium bicarbonate hydration with individual therapies in the reduction of Contrast-induced Nephropathy during Cardiac Catheterisation and Percutaneous Coronary Intervention (CONTRAST): A multi-centre, randomised, controlled trial. Int. J. Cardiol. 2015; 201: 237–242. http://doi.org/10.1016/j.ijcard.2015.07.108Chong E., Poh K.K., Lu Q. et al. Comparison of combination therapy of high-dose oral N-acetylcysteine and intravenous sodium bicarbonate hydration with individual therapies in the reduction of Contrast-induced Nephropathy during Cardiac Catheterisation and Percutaneous Coronary Intervention (CONTRAST): A multi-centre, randomised, controlled trial. Int. J. Cardiol. 2015; 201: 237–242. http://doi.org/10.1016/j.ijcard.2015.07.108Usmiani T., Andreis A., Budano C. et al. AKIGUARD (Acute Kidney Injury GUARding Device) trial: in-hospital and one-year outcomes. J. Cardiovasc. Med. Hagerstown. Md. 2016; 17 (7): 530–537. http://doi.org/10.2459/JCM.0000000000000348Usmiani T., Andreis A., Budano C. et al. AKIGUARD (Acute Kidney Injury GUARding Device) trial: in-hospital and one-year outcomes. J. Cardiovasc. Med. Hagerstown. Md. 2016; 17 (7): 530–537. http://doi.org/10.2459/JCM.0000000000000348Stevens M.A., McCullough P.A., Tobin K.J. et al. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radio contrast Induced Nephropathy Clinical Evaluation. J. Am. Coll. Cardiol. 1999; 33 (2): 403–411. http://doi.org/10.1016/s0735-1097(98)00574-9Stevens M.A., McCullough P.A., Tobin K.J. et al. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radio contrast Induced Nephropathy Clinical Evaluation. J. Am. Coll. Cardiol. 1999; 33 (2): 403–411. http://doi.org/10.1016/s0735-1097(98)00574-9Briguori C., Visconti G., Focaccio A. et al.; REMEDIAL II Investigators. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury. Circulation. 2011; 124 (11): 1260–1269. http://doi.org/10.1161/CIRCULATIONAHA.111.030759Briguori C., Visconti G., Focaccio A. et al.; REMEDIAL II Investigators. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury. Circulation. 2011; 124 (11): 1260–1269. http://doi.org/10.1161/CIRCULATIONAHA.111.030759Marenzi G., Ferrari C., Marana I. et al. Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial. JACC Cardiovasc. Interv. 2012; 5 (1): 90–97. http://doi.org/10.1016/j.jcin.2011.08.017Marenzi G., Ferrari C., Marana I. et al. Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial. JACC Cardiovasc. Interv. 2012; 5 (1): 90–97. http://doi.org/10.1016/j.jcin.2011.08.017Aslanger E., Uslu B., Akdeniz C. et al. Intrarenal application of N-acetylcysteine for the prevention of contrast mediuminduced nephropathy in primary angioplasty. Coron. Artery Dis. 2012; 23 (4): 265–270. http://doi.org/10.1097/MCA.0b013e328351aaccAslanger E., Uslu B., Akdeniz C. et al. Intrarenal application of N-acetylcysteine for the prevention of contrast mediuminduced nephropathy in primary angioplasty. Coron. Artery Dis. 2012; 23 (4): 265–270. http://doi.org/10.1097/MCA.0b013e328351aaccInda-Filho A.J., Caixeta A., Manggini M., Schor N. Do intravenous N-acetylcysteine and sodium bicarbonate prevent high osmolal contrast-induced acute kidney injury? A randomized controlled trial. PloS One. 2014; 9 (9): e107602. http://doi.org/10.1371/journal.pone.0107602Inda-Filho A.J., Caixeta A., Manggini M., Schor N. Do intravenous N-acetylcysteine and sodium bicarbonate prevent high osmolal contrast-induced acute kidney injury? A randomized controlled trial. PloS One. 2014; 9 (9): e107602. http://doi.org/10.1371/journal.pone.0107602Jaffery Z., Verma A., White C.J. et al. A randomized trial of intravenous n-acetylcysteine to prevent contrast induced nephropathy in acute coronary syndromes. Catheter. Cardiovasc. Interv. Off. J. Soc. Card. Angiogr. Interv. 2012; 79 (6): 921–926. http://doi.org/10.1002/ccd.23157Jaffery Z., Verma A., White C.J. et al. A randomized trial of intravenous n-acetylcysteine to prevent contrast induced nephropathy in acute coronary syndromes. Catheter. Cardiovasc. Interv. Off. J. Soc. Card. Angiogr. Interv. 2012; 79 (6): 921–926. http://doi.org/10.1002/ccd.23157O’Sullivan S., Healy D.A., Moloney M.C. et al. The role of N--acetylcysteine in the prevention of contrast-induced nephropathy in patients undergoing peripheral angiography: a structured review and meta-analysis. Angiology. 2013; 64 (8): 576–582. http://doi.org/10.1177/0003319712467223O’Sullivan S., Healy D.A., Moloney M.C. et al. The role of N--acetylcysteine in the prevention of contrast-induced nephropathy in patients undergoing peripheral angiography: a structured review and meta-analysis. Angiology. 2013; 64 (8): 576–582. http://doi.org/10.1177/0003319712467223Poletti P.A., Platon A., De Seigneux S. et al. N-acetylcysteine does not prevent contrast nephropathy in patients with renal impairment undergoing emergency CT: a randomized study. BMC Nephrol. 2013; 14: 119. http://doi.org/10.1186/1471-2369-14-119Poletti P.A., Platon A., De Seigneux S. et al. N-acetylcysteine does not prevent contrast nephropathy in patients with renal impairment undergoing emergency CT: a randomized study. BMC Nephrol. 2013; 14: 119. http://doi.org/10.1186/1471-2369-14-119Kang X., Hu D.Y., Li C.B. et al. N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with pre-existing renal insufficiency or diabetes: a systematic review and meta-analysis. Ren. Fail. 2015; 37 (10): 297–303. http://doi.org/10.3109/0886022X.2015.1012985Kang X., Hu D.Y., Li C.B. et al. N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with pre-existing renal insufficiency or diabetes: a systematic review and meta-analysis. Ren. Fail. 2015; 37 (10): 297–303. http://doi.org/10.3109/0886022X.2015.1012985Ratcliffe J.A., Thiagarajah P., Chen J. et al. Prevention of contrast-induced nephropathy: A randomized controlled trial of sodium bicarbonate and N-acetylcysteine. Int. J. Angiol. Off. Publ. Int. Coll. Angiol. Inc. 2009; 18 (4): 193–197. http://doi.org/10.1055/s-0031-1278353Ratcliffe J.A., Thiagarajah P., Chen J. et al. Prevention of contrast-induced nephropathy: A randomized controlled trial of sodium bicarbonate and N-acetylcysteine. Int. J. Angiol. Off. Publ. Int. Coll. Angiol. Inc. 2009; 18 (4): 193–197. http://doi.org/10.1055/s-0031-1278353Su X., Xie X., Liu L. et al. Comparative Effectiveness of 12 Treatment Strategies for Preventing Contrast-Induced Acute Kidney Injury: A Syste matic Review and Bayesian Network Meta-analysis. Am. J. Kidney Dis. Off. J. Natl. Kidney Found. 2017; 69 (1): 69–77. http://doi.org/10.1053/j.ajkd.2016.07.033Su X., Xie X., Liu L. et al. Comparative Effectiveness of 12 Treatment Strategies for Preventing Contrast-Induced Acute Kidney Injury: A Syste matic Review and Bayesian Network Meta-analysis. Am. J. Kidney Dis. Off. J. Natl. Kidney Found. 2017; 69 (1): 69–77. http://doi.org/10.1053/j.ajkd.2016.07.033Ali-Hasan-Al-Saegh S., Mirhosseini S.J., Ghodratipour Z. et al. Strategies Preventing Contrast-Induced Nephropathy After Coronary Angiography: A Comprehensive MetaAnalysis and Systematic Review of 125 Randomized Controlled Trials. Angiology. 2017; 68 (5): 389–413. http://doi.org/10.1177/0003319716661445Ali-Hasan-Al-Saegh S., Mirhosseini S.J., Ghodratipour Z. et al. Strategies Preventing Contrast-Induced Nephropathy After Coronary Angiography: A Comprehensive MetaAnalysis and Systematic Review of 125 Randomized Controlled Trials. Angiology. 2017; 68 (5): 389–413. http://doi.org/10.1177/0003319716661445Subramaniam R.M., Suarez-Cuervo C., Wilson R.F. et al. Effectiveness of Prevention Strategies for ContrastInduced Nephropathy: A Syste matic Review and Metaanalysis. Ann. Intern. Med. 2016; 164 (6): 406–416. http://doi.org/10.7326/M15-1456Subramaniam R.M., Suarez-Cuervo C., Wilson R.F. et al. Effectiveness of Prevention Strategies for ContrastInduced Nephropathy: A Syste matic Review and Metaanalysis. Ann. Intern. Med. 2016; 164 (6): 406–416. http://doi.org/10.7326/M15-1456Jo S.H., Lee J.M., Park J., Kim H.S. The impact of reninangiotensin-aldosterone system blockade on contrastinduced nephropathy: a meta-analysis of 12 studies with 4,493 patients. Cardiology. 2015; 130 (1): 4–14. http://doi.org/10.1159/000366473Jo S.H., Lee J.M., Park J., Kim H.S. The impact of reninangiotensin-aldosterone system blockade on contrastinduced nephropathy: a meta-analysis of 12 studies with 4,493 patients. Cardiology. 2015; 130 (1): 4–14. http://doi.org/10.1159/000366473Brueck M., Cengiz H., Hoeltgen R. et al. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a singlecenter, prospective, randomized, double-blind, placebocontrolled trial. J. Invasive Cardiol. 2013; 25 (6): 276–283.Brueck M., Cengiz H., Hoeltgen R. et al. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a singlecenter, prospective, randomized, double-blind, placebocontrolled trial. J. Invasive Cardiol. 2013; 25 (6): 276–283.Albabtain M.A., Almasood A., Alshurafah H. et al. Efficacy of ascorbic acid, N-acetylcysteine, or combination of both on top of saline hydration versus saline hydration alone on prevention of contrast-Induced nephropathy: a prospective randomized study. J. Interv. Cardiol. 2013; 26 (1): 90–96. http://doi.org/10.1111/j.1540-8183.2012.00767.xAlbabtain M.A., Almasood A., Alshurafah H. et al. Efficacy of ascorbic acid, N-acetylcysteine, or combination of both on top of saline hydration versus saline hydration alone on prevention of contrast-Induced nephropathy: a prospective randomized study. J. Interv. Cardiol. 2013; 26 (1): 90–96. http://doi.org/10.1111/j.1540-8183.2012.00767.xSong K., Jiang S., Shi Y. et al. Renal replacement therapy for prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials. Am. J. Nephrol. 2010; 32 (5): 497–504. http://doi.org/10.1159/000321344Song K., Jiang S., Shi Y. et al. Renal replacement therapy for prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials. Am. J. Nephrol. 2010; 32 (5): 497–504. http://doi.org/10.1159/000321344Renal replacement therapies for prevention of radiocontrast-induced nephropathy: a systematic review – PubMed. Accessed March 15, 2021. https://pubmed.ncbi.nlm.nih.gov/22195531/Renal replacement therapies for prevention of radiocontrast-induced nephropathy: a systematic review – PubMed. Accessed March 15, 2021. https://pubmed.ncbi.nlm.nih.gov/22195531/van der Molen A.J., Reimer P., Dekkers I.A. et al. Postcontrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients. Eur. Radiol. 2018; 28 (7): 2856–2869. http://doi.org/10.1007/s00330-017-5247-4van der Molen A.J., Reimer P., Dekkers I.A. et al. Postcontrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients. Eur. Radiol. 2018; 28 (7): 2856–2869. http://doi.org/10.1007/s00330-017-5247-4Timal R.J., Kooiman J., Sijpkens Y.W.J. et al. Effect of No Prehydration vs Sodium Bicarbonate Prehydration Prior to Contrast-Enhanced Computed Tomography in the Prevention of Postcontrast Acute Kidney Injury in Adults With Chronic Kidney Disease: The Kompas Randomized Clinical Trial. JAMA Intern. Med. 2020; 180 (4): 533–541. http://doi.org/10.1001/jamainternmed.2019.7428Timal R.J., Kooiman J., Sijpkens Y.W.J. et al. Effect of No Prehydration vs Sodium Bicarbonate Prehydration Prior to Contrast-Enhanced Computed Tomography in the Prevention of Postcontrast Acute Kidney Injury in Adults With Chronic Kidney Disease: The Kompas Randomized Clinical Trial. JAMA Intern. Med. 2020; 180 (4): 533–541. http://doi.org/10.1001/jamainternmed.2019.7428Liao Y.B., Deng X.X., Meng Y. et al. Predictors and outcome of acute kidney injury after transcatheter aortic valve implantation: a systematic review and meta-analysis. EuroIntervention J. Eur. Collab. Work. Group Interv. Cardiol. Eur. Soc. Cardiol. 2017; 12 (17): 2067–2074. http://doi.org/10.4244/EIJ-D-15-00254Liao Y.B., Deng X.X., Meng Y. et al. Predictors and outcome of acute kidney injury after transcatheter aortic valve implantation: a systematic review and meta-analysis. EuroIntervention J. Eur. Collab. Work. Group Interv. Cardiol. Eur. Soc. Cardiol. 2017; 12 (17): 2067–2074. http://doi.org/10.4244/EIJ-D-15-00254Arbel Y., Ben-Assa E., Puzhevsky D. et al. Forced diuresis with matched hydration during transcatheter aortic valve implantation for Reducing Acute Kidney Injury: a randomized, sham-controlled study (REDUCEAKI). Eur. Heart J. 2019; 40 (38): 3169–3178. http://doi.org/10.1093/eurheartj/ehz343Arbel Y., Ben-Assa E., Puzhevsky D. et al. Forced diuresis with matched hydration during transcatheter aortic valve implantation for Reducing Acute Kidney Injury: a randomized, sham-controlled study (REDUCEAKI). Eur. Heart J. 2019; 40 (38): 3169–3178. http://doi.org/10.1093/eurheartj/ehz343Barbanti M., Gulino S., Capranzano P. et al. Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECTTAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation). JACC Cardiovasc. Interv. 2015; 8 (12): 1595–1604. http://doi.org/10.1016/j.jcin.2015.07.012Barbanti M., Gulino S., Capranzano P. et al. Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECTTAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation). JACC Cardiovasc. Interv. 2015; 8 (12): 1595–1604. http://doi.org/10.1016/j.jcin.2015.07.012Chorin E., Ben-Assa E., Konigstein M. et al. Prevention of postprocedural acute kidney injury in the catheterization laboratory in a real-world population. Int. J. Cardiol. 2017; 226: 42–47. http://doi.org/10.1016/j.ijcard.2016.10.028Chorin E., Ben-Assa E., Konigstein M. et al. Prevention of postprocedural acute kidney injury in the catheterization laboratory in a real-world population. Int. J. Cardiol. 2017; 226: 42–47. http://doi.org/10.1016/j.ijcard.2016.10.028Semler M.W., Self W.H., Wanderer J.P. et al. Balanced Crystalloids versus Saline in Critically Ill Adults. N. Engl. J. Med. 2018; 378 (9): 829–839. http://doi.org/10.1056/NEJMoa1711584Semler M.W., Self W.H., Wanderer J.P. et al. Balanced Crystalloids versus Saline in Critically Ill Adults. N. Engl. J. Med. 2018; 378 (9): 829–839. http://doi.org/10.1056/NEJMoa1711584Kidney Injury Is Not Prevented By Hydration Alone. Medscape. Accessed March 15, 2021. http://www.medscape.com/viewarticle/920237Kidney Injury Is Not Prevented By Hydration Alone. Medscape. Accessed March 15, 2021. http://www.medscape.com/viewarticle/920237Marashizadeh A., Sanati H.R., Sadeghipour P. et al. Left ventricular end-diastolic pressure-guided hydration for the prevention of contrast-induced acute kidney injury in patients with stable ischemic heart disease: the LAKESIDE trial. Int. Urol. Nephrol. 2019; 51 (10): 1815– 1822. http://doi.org/10.1007/s11255-019-02235-wMarashizadeh A., Sanati H.R., Sadeghipour P. et al. Left ventricular end-diastolic pressure-guided hydration for the prevention of contrast-induced acute kidney injury in patients with stable ischemic heart disease: the LAKESIDE trial. Int. Urol. Nephrol. 2019; 51 (10): 1815– 1822. http://doi.org/10.1007/s11255-019-02235-wQian G., Liu C., Guo J. et al. Prevention of contrastinduced nephropathy by adequate hydration combined with isosorbide dinitrate for patients with renal insufficiency and congestive heart failure. Clin. Cardiol. 2019; 42 (1): 21–25. http://doi.org/10.1002/clc.23023Qian G., Liu C., Guo J. et al. Prevention of contrastinduced nephropathy by adequate hydration combined with isosorbide dinitrate for patients with renal insufficiency and congestive heart failure. Clin. Cardiol. 2019; 42 (1): 21–25. http://doi.org/10.1002/clc.23023Kooiman J., de Vries J., Van der Heyden J. et al. Randomized trial of one-hour sodium bicarbonate vs standard periprocedural saline hydration in chronic kidney disease patients undergoing cardiovascular contrast procedures. PloS One. 2018; 13 (2): e0189372. http://doi.org/10.1371/journal.pone.0189372Kooiman J., de Vries J., Van der Heyden J. et al. Randomized trial of one-hour sodium bicarbonate vs standard periprocedural saline hydration in chronic kidney disease patients undergoing cardiovascular contrast procedures. PloS One. 2018; 13 (2): e0189372. http://doi.org/10.1371/journal.pone.0189372

The authors declare that there are no conflicts of interest present.